Title : The effects of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild-to-moderate asthma.

Pub. Date : 2014 Sep

PMID : 25040039






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The effects of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild-to-moderate asthma. 4-(4-(aminomethyl)-7a-methyl-1-methylideneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexan-1-ol inositol polyphosphate-5-phosphatase D Homo sapiens
2 AQX-1125 is a first-in-class, oral SHIP1 activator with a novel anti-inflammatory mode of action. 4-(4-(aminomethyl)-7a-methyl-1-methylideneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexan-1-ol inositol polyphosphate-5-phosphatase D Homo sapiens
3 CONCLUSION AND CLINICAL RELEVANCE: AQX-1125, a novel oral SHIP1 activator, significantly reduces the late response to allergen challenge, with a trend to reduce airway inflammation. 4-(4-(aminomethyl)-7a-methyl-1-methylideneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexan-1-ol inositol polyphosphate-5-phosphatase D Homo sapiens